| # | Phamarceutical | Rank | Revenue | Profit | % profit per revenue |
| 1 | Johnson & Johnson | 107 | 61,095 | 10,576 | 17.3 |
| 2 | Pfizer | 143 | 48,418 | 8,144 | 16.8 |
| 3 | GlaxoSmithKline | 151 | 45,447 | 10,432 | 23.0 |
| 4 | Roche Group | 175 | 40,315 | 8,135 | 20.2 |
| 5 | Sanofi-Aventis | 178 | 39,977 | 7,204 | 18.0 |
| 6 | Novartis | 181 | 39,800 | 11,946 | 30.0 |
| 7 | AstraZeneca | 265 | 29,559 | 5,595 | 18.9 |
| 8 | Abbott Laboratories | 312 | 25,914 | 3,606 | 13.9 |
| 9 | Merck | 332 | 24,198 | 3,275 | 13.5 |
| 10 | Wyeth | 381 | 22,400 | 4,616 | 20.6 |
| 11 | Bristol-Myers Squibb | 427 | 19,977 | 2,165 | 10.8 |
| 12 | Eli Lilly | 453 | 18,634 | 2,953 | 15.8 |
Revenue, profit in USD Millions
source: Global Fortune 500
